{{Rsnum
|rsid=17542768
|Gene=FGFR2
|Chromosome=10
|position=123337814
|Orientation=plus
|GMAF=0.09963
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 76.1 | 22.1 | 1.8
| HCB | 81.8 | 16.8 | 1.5
| JPT | 85.0 | 15.0 | 0.0
| YRI | 90.5 | 8.8 | 0.7
| ASW | 86.0 | 14.0 | 0.0
| CHB | 81.8 | 16.8 | 1.5
| CHD | 83.5 | 13.8 | 2.8
| GIH | 63.4 | 33.7 | 3.0
| LWK | 92.7 | 6.4 | 0.9
| MEX | 75.9 | 24.1 | 0.0
| MKK | 92.9 | 7.1 | 0.0
| TSI | 76.5 | 21.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21822685
|Title=Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality
}}

{{PMID|18285324|OA=1
}} Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}